You May Already Be Immune to CRISPR – The Atlantic
The Atlantic |
You May Already Be Immune to CRISPR
The Atlantic In statements to The Atlantic, three of the leading companies in CRISPR human therapy—Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics—all downplayed the new findings, citing various ways their therapies could around the immune system … CRISPR gene editor could spark immune reaction in people CRISPR hits a snag: Our immune systems may attack the treatment New Research Suggests Immunity to CRISPR Gene Editing Poses a Challenge |
